The Implantable Loop Recorders (ILR) market offers opportunities through enhanced long-term cardiac monitoring over traditional methods, global and regional trends analysis, regulatory insights, and ...

Though the trial demonstrates the feasibility of the approach, future research is needed to assess the clinical impact.

Presence of cardiac fibrosis puts high-level endurance athletes at increased risk for ventricular tachycardia while ...

Dutch trial establishes feasibility of screening approach in routine specialty care ...

First‑in‑class SK ion channel inhibitor enters next stage of clinical development Acesion Pharma has begun enrolling patients into a phase 2 clinical trial of AP31969, its novel oral SK ion channel ...

Veteran male athletes who have spent years training at high intensity may be at greater risk of serious heart problems while ...

Veteran male athletes who have spent years training at high intensity may be at greater risk of serious heart problems while exercising, new ...

Veteran male athletes who have spent years training at high intensity may be at greater risk of serious heart problems while exercising, new University of Leeds research shows. The study shows that ...

AP31969 is a novel, first-in-class, oral SK ion channel inhibitor intended for rhythm control of atrial fibrillation and has recently completed Phase 1 in healthy volunteers Phase 2 trial will assess ...

The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.

The last time I drove a car on the public road was a year ago yesterday, on my way home from the MOT in Ballymena. To celebrate, I had a piece of my birthday cake when I got home, and promptly choked ...

Revolutionary technologies like pulsed field ablation and structural heart therapies are driving rapid market expansion.